U.S. markets closed

Galectin Therapeutics, Inc. (GALT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.8700+0.2600 (+9.96%)
At close: 4:00PM EDT

2.8600 -0.01 (-0.35%)
After hours: 7:57PM EDT

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 8/12/2020
Current
6/30/20203/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
149.45M174.51M111.78M162.72M207.94M232.38M
Enterprise Value 3
111.02M133.52M66.60M114.68M158.19M227.70M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/AN/A
Price/Book (mrq)
4.304.312.583.454.2151.26
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
-6.35-21.94-18.89-22.46-57.44-76.69

Trading Information

Stock Price History

Beta (5Y Monthly) 2.41
52-Week Change 3-21.62%
S&P500 52-Week Change 318.71%
52 Week High 34.5000
52 Week Low 31.5000
50-Day Moving Average 32.7677
200-Day Moving Average 32.4851

Share Statistics

Avg Vol (3 month) 3182.94k
Avg Vol (10 day) 3159.85k
Shares Outstanding 557.03M
Float 41.1M
% Held by Insiders 128.34%
% Held by Institutions 117.47%
Shares Short (Jul 30, 2020) 45.49M
Short Ratio (Jul 30, 2020) 437.85
Short % of Float (Jul 30, 2020) 417.97%
Short % of Shares Outstanding (Jul 30, 2020) 49.63%
Shares Short (prior month Jun 29, 2020) 45.55M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Mar 22, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-23.50%
Return on Equity (ttm)-39.69%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-17.75M
Diluted EPS (ttm)-0.3120
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)40.77M
Total Cash Per Share (mrq)0.71
Total Debt (mrq)72k
Total Debt/Equity (mrq)0.19
Current Ratio (mrq)9.62
Book Value Per Share (mrq)0.61

Cash Flow Statement

Operating Cash Flow (ttm)-12.21M
Levered Free Cash Flow (ttm)-6.2M